The observation that intravenous reconstituted HDL (rHDL) reduced plasma glucose in patients with type 2 diabetes mellitus by increasing plasma insulin and stimulating AMP-activated protein kinase in skeletal muscle further supports the view that HDLs have the capacity to improve diabetic control and probably postpone the development of new diabetes via several mechanisms [27]. This evidence concerns the gene INS and diabetes mellitus.